Statistics for CytoSorbentsrp (id:5554 CTSO)

Valuation metrics

Market cap

52.80M

Enterprise value

71.97M

Trailing P/E (ttm)

-1.43

Forward P/E

-6.93

PEG ratio

-6.93

Price/Sales (ttm)

1.40

Price/Book (mrq)

4.06

Enterprise Value/Revenue

1.91

Enterprise Value/EBITDA

-3.65

Overview

Shares outstanding

54.43M

Float

46.34M

Shares short

1.35M

% Held by insiders

0.04%

% Held by institutions

0.35%

Average volume (10 days)

187.04K

Average volume (90 days)

Price summary

52-Week low

0.70

52-Week high

2.15

52-Week change

-35.39%

Beta

0.56

50-Day moving average

1.13

200-Day moving average

0.99

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

December 05th, 2014

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

-49.47%

Operating margin

-46.14%

Operational effectiveness

Return on assets

-27.93%

Return on equity

-118.50%

Income statement

Revenue (ttm)

0.72

Revenue per share (ttm)

0.72

Quarterly revenue growth (yoy)

Gross profit (ttm)

17.13M

EBITDA

-19,732,864.00

Net income to common (ttm)

-18,670,004.00

Diluted EPS (ttm)

-0.52

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

5.69M

Total cash per share (mrq)

0.10

Total debt (mrq)

26.81M

Total Debt/Equity (mrq)

206.22

Current ratio (mrq)

196.90%

Book value per share (mrq)

0.24

Cash flow

Cash flow statement

-18,493,052.00

Levered free cash flow (LFCF)

-11,946,897.00